Growth Metrics

Fulgent Genetics (FLGT) Depreciation & Amortization (CF) (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Depreciation & Amortization (CF) for 11 consecutive years, with $6.1 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 1.29% to $6.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.0 million through Dec 2025, up 36.61% year-over-year, with the annual reading at $24.1 million for FY2025, 3.23% down from the prior year.
  • Depreciation & Amortization (CF) hit $6.1 million in Q4 2025 for Fulgent Genetics, up from $110000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $9.8 million in Q3 2022 to a low of $110000.0 in Q3 2025.
  • Historically, Depreciation & Amortization (CF) has averaged $5.1 million across 5 years, with a median of $6.0 million in 2025.
  • Biggest five-year swings in Depreciation & Amortization (CF): crashed 97.37% in 2024 and later soared 3284.48% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $3.5 million in 2021, then skyrocketed by 180.78% to $9.8 million in 2022, then tumbled by 33.35% to $6.5 million in 2023, then decreased by 5.22% to $6.2 million in 2024, then dropped by 1.29% to $6.1 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for FLGT at $6.1 million in Q4 2025, $110000.0 in Q3 2025, and $5.9 million in Q2 2025.